Preliminary scientific tests indicate conolidine may possibly inhibit distinct ion channels, cutting down neuronal excitability and limiting agony indicators. This system is particularly relevant in neuropathic soreness, where abnormal signaling triggers persistent pain. Moreover, conolidine appears to impact G protein-coupled receptor (GPCR) pathw